FDA chief tells reporter 'move on' when pressed on Biogen Alzheimer's drug approval
July 14, 2021 at 16:15 PM EDT
Acting FDA Commissioner Dr. Janet Woodcock pushed back against questions from a journalist about the approval of Biogen's Alzheimer's medication, Aduhelm.
